Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine

The leishmaniases are a complex of vector-borne diseases caused by protozoan parasites of the genus Leishmania. LEISHDNAVAX is a multi-antigen, T-cell epitope-enriched DNA vaccine candidate against human leishmaniasis. The vaccine candidate has been proven immunogenic and showed prophylactic efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Riede, O, Seifert, K, Oswald, D, Endmann, A, Hock, C, Winkler, A, Salguero, F J, Schroff, M, Croft, S L, Juhls, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530203/
https://www.ncbi.nlm.nih.gov/pubmed/25871827
http://dx.doi.org/10.1038/gt.2015.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530203/
https://www.ncbi.nlm.nih.gov/pubmed/25871827
http://dx.doi.org/10.1038/gt.2015.35

Ejemplares similares